Whilst not trying to sound callous, I'd assume these patients, having advanced cancers that had not reacted favourably to previous treatments, would be in fairly poor state of health before commencing this radio-therapy trial? Clearly that must have significant deleterious impact on the survival rate regardless of how good the Cu67 treatment may be?
Any doctor care to respond?
Research/Valuation, page-516
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.65 |
Change
-0.050(0.57%) |
Mkt cap ! $2.734B | |||
| Open | High | Low | Value | Volume |
| $8.65 | $8.79 | $8.40 | $14.40M | 1.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59 | $8.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.65 | 21036 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |